- Original article
- Open access
- Published:
Creatinine, cystatin, and combined-based equations in assessment of renal functions in type 2 diabetic Egyptian patients
The Egyptian Journal of Internal Medicine volume 29, pages 105–111 (2017)
Abstract
Background
Diabetic nephropathy is the principal single cause of end-stage renal disease. The most important parameter in the clinical evaluation of kidney function is the glomerular filtration rate (GFR), which is generally accepted as the best overall index of kidney function; GFR remains the cornerstone of the clinical evaluation of overall kidney function. Our study was performed to compare between estimated GFR equations based on serum creatinine and/or cystatin C performance in relation to measured GFR using radionuclide study and degree of proteinuria.
Patients and methods
In our cross-sectional study, 80 adult type 2 diabetic patients, with diabetic nephropathy and proteinuria more than 300 mg/24h, were included after application of inclusion and exclusion criteria, and subjected to history taking, clinical examination, and laboratory investigation including serum creatinine, cystatin C, 24-h urinary protein/creatinine clearance, and renal isotope technetium-99m-diethylene triamine pentaacetic acid scanning.
Results
There was a linear correlation between serum creatinine and cystatin C (r=0.867, P=0.000). Cystatin C was better correlated (r=-0.781, P=0.000) with isotopically measured GFR than creatinine (r=-0.106, P=0.348). Cystatin C was better than creatinine in all estimated GFR equations tested in our study [Modification of Diet in Renal Disease, Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Cr 2009, CKD-EPI Cr-Cys2012, CKD-EPI Cys 2012]. Thebest performance among all equations tested when compared with isotopically measured GFR was the CKD-EPI Cr-Cyst 2012 (r=0.816, P=0.000). Cystatin C showed a significant negative correlation with hemoglobin level, a finding that could not be established with serum creatinine; there was no significant association of creatinine or cystatin with the level of proteinuria.
Conclusion
In patients with early overt diabetic nephropathy, serum cystatin C showed a significantly stronger correlation than creatinine with isotopically measured GFR, and among the studied equations for GFR estimation the CKD-EPI Cr-Cyst 2012 equation performed best.
References
Rodrigo E, Fernández-Fresnedo G, Castañeda O, Arias M Estimation of renal function in adult kidney transplant recipients by equations. Transplant Rev 2007; 212:1–16.
Michael M, McGwan NF, Gross JL, de Azevedo MJ, Silveiro SP, et al. Clinical course management of diabetic nephropathy. Diabetes Care 2005; 27:15–35.
MacIsaac RJ, Premaratne E, Jerums G. Estimating glomerular filtration rate in diabetes using serum cystatin C. Clin Biochem Rev 2011; 32:61–67.
Stevens LA, Coresh J, Schmid CH, Feldman HL, Froissart M, Kusek J. Estimating GFR using serum cystatin C alone and combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51:395–406.
Ziessman HA, O’ Malley J, et al. Imaging techniques, in the requisites and radiology. Radiology 2006; 200:283–320.
González-SolÃs J, Oro D, Pedrocchi V, Jover L, Ruiz X. Bias associated with diet samples in Audouin’s gulls. Condor 1997; 99:773–779.
American Diabetic Association. Standard medical care of diabetes. Diabetes Care 2009; 32:513–561.
Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998; 58:585–592.
Al-Malki N, Heidenheim PA, et al. Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities. Clin J Am Soc Nephrol 2009; 4:1606–1610.
Perkins BA, Nelson R, et al. Detection of renal function decline in patient with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol 2005; 16:1404–1412.
Premaratne E, MacIsaac R, Finch S, Panagiotopoulos S, Ekinci E, Jerums G. Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes. Diabetes Care 2008; 31:971–973.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–612.
Menon V, Wang X, Sarnak MJ, Hunsicker LH, Madero M, Beck GJ, et al. Longterm outcomes in nondiabetic chronic kidney disease. Kidney Int 2008; 73:1310–1315.
Ibrahim H, Mondress M, et al. An alternative formula to the Cockcroft-Gault and the Modification of Diet in Renal Disease formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol 2005; 16:1051–1060.
Stevens LA, Schmid CH, et al. Development and validation of GFR estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant 2009; 25:449–457.
Inker LA, Schmid CH, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367:20–29.
Trimarchi H, Muryan A, et al. Proteinuria, 99mTc-DTPA scintigraphy, creatinine, cyatatin and combined-based equations in the assessment of chronic kidney disease. ISRN Nephrol 2014; 2014:430247.
Knight EL, Verhave JC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65:1416–1421.
Shlipak MG, Mastsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function N Engl J Med 2013; 369:932–943.
Chritensen PK, Larsen S, Horn T, Olsen S, Parving HH. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int 2000; 58:1719–1731.
Musallam K, Taher A. Mechanisms of renal disease in B-thalassemia. J Am Soc Nephrol 2012; 23:1299–1302.
Asnani M, Reid M. Cystatin C: a useful marker of glomerulopathy in sickle cell disease? Blood Cells Mol Dis 2015; 54:65–70.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Elnokeety, M.M., Shaker, A.M. & Fayed, A.M. Creatinine, cystatin, and combined-based equations in assessment of renal functions in type 2 diabetic Egyptian patients. Egypt J Intern Med 29, 105–111 (2017). https://doi.org/10.4103/ejim.ejim_26_17
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejim.ejim_26_17